The Newton, Massachusetts–based company Auron Therapeutics has received $48 million in series A financing from investors including DCVC Bio and Eli Lilly and Company. Auron will expand its machine ...
NEWTON, Mass., July 20, 2022 (GLOBE NEWSWIRE) -- Auron Therapeutics (“Auron”), a biopharmaceutical company focused on developing therapies that target dysregulated differentiation and cellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results